StreetInsider.com News Articles

Form 424B4 Electra Therapeutics,

Fri, 18 Sep 2026 16:53:00 -0400

si-local-file:///var/storage/secattach/20260918/27081129.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: ORBIMED ADVISORS LLC

Fri, 18 Sep 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260918/27081085.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Tucker David J.

Fri, 18 Sep 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260918/27080839.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Fust Matthew K

Fri, 18 Sep 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260918/27080796.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Dao Kim-Hien

Fri, 18 Sep 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260918/27080774.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Parry Graham

Fri, 18 Sep 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260918/27080750.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Parry Graham

Fri, 18 Sep 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260918/27080752.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: GORDON CARL L

Fri, 18 Sep 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260918/27080734.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Koe Gary S.

Fri, 18 Sep 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260918/27080736.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Clark Christopher William

Fri, 18 Sep 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260918/27080727.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Dong Quehuong (Kathy)

Fri, 18 Sep 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260918/27080703.html

Form 3 Electra Therapeutics, For: Sep 18 Filed by: Stagliano Nancy

Fri, 18 Sep 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260918/27080713.html

Electra Therapeutics indicated to open at $20, IPO priced at $15

Fri, 18 Sep 2026 10:41:40 -0400

Electra Therapeutics indicated to open at $20, IPO priced at $15

Form CERT Electra Therapeutics,

Fri, 18 Sep 2026 08:21:00 -0400

si-local-file:///var/storage/secattach/20260918/27078465.html

Form EFFECT Electra Therapeutics,

Fri, 18 Sep 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260918/27077818.html

Form 8-A12B Electra Therapeutics,

Fri, 18 Sep 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260918/27077826.html

Form S-1MEF Electra Therapeutics,

Thu, 17 Sep 2026 19:06:00 -0400

si-local-file:///var/storage/secattach/20260917/27077114.html

Electra Therapeutics IPO expected to price above midpoint

Thu, 17 Sep 2026 10:59:52 -0400

Investing.com -- Electra Therapeutics Inc. anticipates its initial public offering will price in the upper half of the $14 to $16 range, Bloomberg reported Thursday.

The biotechnology company, which focuses on late-stage immune-mediated disease and cancer treatments, received demand from new and existing institutional investors for several times the number of shares available, according to the report.

The offering is expected to price after the market closes Thursday in New York. Shares are set to begin trading Friday on the Nasdaq Global Select Market under the ticker symbol ETRA.

Electra Therapeutics is offering approximately 21.67 million shares in the offering.

Jefferies Financial Group Inc.,

Electra Is Said to Guide IPO Pricing to Upper Half of Range

Thu, 17 Sep 2026 10:57:11 -0400

Electra Is Said to Guide IPO Pricing to Upper Half of Range - Bloomberg

Electra Therapeutics files for proposed IPO

Fri, 28 Aug 2026 15:54:21 -0400

(Updated - August 28, 2026 3:54 PM EDT)

Electra Therapeutics on Friday filed for a proposed IPO.

The company describes itself as: "We are a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. Our novel approach targets signal regulatory proteins (SIRP), a family of cell surface receptors whose expression is restricted to specific immune cell populations, and increases upon activation to enable selective depletion of disease-driving cells while preserving normal immune function. By replacing broad immunosuppression with selective elimination of principal cells that drive disease, we believe our approach

Electra Therapeutics files for proposed IPO

Fri, 28 Aug 2026 15:54:21 -0400

(Updated - August 28, 2026 3:54 PM EDT)

Electra Therapeutics on Friday filed for a proposed IPO.

Electra Therapeutics files for proposed IPO

Fri, 28 Aug 2026 15:54:21 -0400

(Updated - August 28, 2026 3:54 PM EDT)

Electra Therapeutics on Friday filed for a proposed IPO.